Scroll To Top
Search by Speciality


Kursaal Bern * | Bern , SWITZERLAND
From 169 to 680 EUR
Event Preview
This event
is Finished
Specialty: , Clinical Pharmacology, Nephrology
Dates: From Apr, 9, 2014 to Apr, 12, 2014
Location: Bern , SWITZERLAND
Type: Meeting
Registration Cost: From 169 to 680 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for BERN , Switzerland.
General Info
Event Venue:

Kursaal Bern *

BERN , SWITZERLAND Visit the Venue to read more
Event Overview
Welcome message:

The 6th Drug Hypersensitivity Meeting (DHM6) will take place in Bern, Switzerland, from April 9 – 12, 2014. This biennial event started in Bern in 2004, and was successfully held in Liverpool in 2006, Paris 2008, Rome 2010 and Munich 2012. Now it has returned to Bern. 

DHM is an interdisciplinary meeting, bringing together researchers and physicians from different disciplines to exchange their most up-to-date data in this continually evolving field and to transfer it to clinical practice. It is the leading event of its kind, attracting up to 400 physicians and researchers from all over the world. 

How small (and larger) molecules interact with the immune system and elicit hypersensitivity, toxicity, autoimmunity is still an enigmatic issue. It is not easy to diagnose, as the resulting diseases are often puzzling, and the test procedures are not yet definitively established. The last few years have brought many new insights and dramatically changed our view of hypersensitivity reactions. What was considered unpredictable became, for some drugs, highly predictable. What was bizarre became a well understood disease and  protocols on how to diagnose became available. Simultaneously new issues have arisen, for example, the side effects of biologicals have become a growing concern. So it is time to meet again and to discuss the latest progress with your colleagues in the beautiful city of Bern, an UNESCO heritage site, from 9 – 12 April 2014!

Werner J Pichler 
DHM 2014 Chair

Registration Not yet available Register Now

Accommodation can be booked via Bern Incoming, the Convention and visitors Bureau (CVB) of the city of Bern here

EAACI DHM Speaker Hotels

The Headquarters Speaker hotels are:

Best Western Hotel Bern 
Zeughausgasse 9
3011 Bern
Tel +41 31 329 22 22
Fax +41 31 329 22 99

Hotel Allegro
Kornhausstrasse 3
3000 Bern 25
Tel +41 31 339 55 00
Fax +41 31 339 55 10

Scientific Content Up to Date
Submission Info
Abstract submission will be open from 1 November until 31 January 2014 at 24:00 CET.

Abstracts received after this date will not be considered.

Accepted abstracts will be published on the DHM  2013 website and on the EAACI official online journal, Clinical and Translational Allergy, as a supplement (approximately eight weeks after the meeting), on condition that the presenting author has paid the registration fee and has presented the abstract. 

The presenting author of an abstract must be registered by 21 March 2014.

General abstract information

Abstract topics
Only abstracts related to the following topics will be considered:

• Clinical cases / case series: immediate, IgE 
• Clinical cases / case series: non-immediate, delayed, T cells, IgG
• SJS / TEN / DRESS / AGEP / hepatitis / nephritis / contact dermatitis
• AERD / AECD and other intolerance reactions
• Cofactors: underlying diseases, virus infections, mastocytosis
• Diagnosis in vivo (skin tests)
• Diagnosis in vitro 
• Immunological mechanisms: mast cells, basophils, IgE,...
• Immunological mechanisms: T cells,  cell activations, T-reg, cytotoxicity, NK
• Pharmaco- and immunogenetics
• Risk assessment in vitro / immunotoxicology
• Adverse reactions to biologicals and to new drugs
• Epidemiology, pharmacovigilance and prediction
• Provocation, desensitisation, treatment
• Cross-reactivity, multiple drug hypersensitivity, flare up reactions, 
• Beta lactam hypersensitivities
• Non-betalactam antibiotics, antineoplasic drugs, anesthetics, contrast media, et al.
• Drug hypersensitivity in children
• Miscellaneous

Original laboratory research, clinical research and case presentations are equally welcome.

Abstract regulations

• Abstracts can only be submitted electronically on the DHM 2014 website. The deadline for abstract submission is 31 January 2014 at 24:00 CET.

• Acknowledgement of receipt of your submission will be sent to your stated e-mail address. If you do not receive the confirmatory e-mail within 24 hours, please contact us at:

• Abstracts must be written in English

• Maximum 2,500 characters (approximately 340 words), including spaces but excluding title and contact information of the authors

• It is the author’s responsibility to submit a fully corrected abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author

• It is allowed to be the presenting author of more than one abstract

• It is allowed to be a co-author of an unlimited number of abstracts 

• Submission of closely related abstracts from the same group is discouraged

• Abstracts will only be considered for presentation if they are not published or submitted for presentation elsewhere

• Abstract presenters must be registered for DHM 2014 and pay the registration fee for attendance at the scientific sessions

• Confirmation of your abstract submission will be sent to your e-mail address immediately after submission. A personal user ID and password will also be sent to you and will give access to an Online Personal Page where you can edit your abstract until the online abstract submission closes.

For questions, please send an e-mail to

Notification of acceptance

Notifications of acceptance or rejection of the abstracts will be sent to the corresponding author of the abstract by the 24 February 2014 at the latest. 

Accepted abstracts will be considered for oral or poster presentation.

The corresponding author receives all correspondence concerning the abstract. The corresponding author is responsible for informing all other co-authors of the status of the abstract. 

All abstract presenters will be asked to reconfirm their attendance after receiving the notification. If you don't reconfirm your abstract presentation, register and pay the registration fee before 21 March 2014, your abstract will be removed.

EAACI cannot guarantee that presenting authors who do not show up to present their abstract during the session will be accepted for abstract presentations at future events.

Presentations of abstracts
The accepted abstracts will be presented in Oral Abstract Sessions and Poster Discussion Sessions. 

Publication of abstracts
Accepted abstracts will be available on the DHM 2014 website. Only abstracts presented during the DHM 2014 Symposium will be published in the CTA Journal after the meeting.

EAACI travel grant
All JMA abstract presenters are automatically entered in  the competition of the EAACI Travel Grant of EUR 300 each. The winners will be notified prior to the meeting and travel costs will be refunded after the meeting.

For abstract submission support please contact EAACI HQ at:
Sponsors Exhibitors
Organising Agency

European Academy of Allergy & Clinical Immunology Headquarters

Phone: 011-41-44-205-5533

Fax: 011-41-44-205-5539

Official Event Webpage
Event map
Revelant Events